Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients

A. Galstyan (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), M. Sinitsyn (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation), L. Slogodskay (Moscow, Russian Federation)

Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Session: Extra-pulmonary tuberculosis and comorbidities
Session type: Thematic Poster
Number: 2990

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Galstyan (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), M. Sinitsyn (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation), L. Slogodskay (Moscow, Russian Federation). Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients. 2990

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: